Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2468)
All Articles published online
|
Mar 21, 2008 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Breuhahn K, Schirmacher P. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1690-1698 [PMID: 18350600 DOI: 10.3748/wjg.14.1690] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1690.htm |
| Number | Citing Articles |
| 1 |
Haijian Zhang, Min Yao, Wei Wu, Liwei Qiu, Wenli Sai, Junling Yang, Wenjie Zheng, Jianfei Huang, Dengfu Yao. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. Tumor Biology 2015; 36(12): 9373 doi: 10.1007/s13277-015-3678-6
|
| 2 |
Na Huang, Fanpu Ji, Shu Zhang, Yansong Pu, An Jiang, Rui Zhou, Yuanyuan Ji, Wei Wei, Jun Yang, Zongfang Li. Effect of Splenectomy on Serum Cytokine Profiles in Hepatitis B Virus-Related Cirrhosis Patients with Portal Hypertension. Viral Immunology 2018; 31(5): 371 doi: 10.1089/vim.2017.0176
|
| 3 |
Zara Zelenko, Derek LeRoith, Emily J. Gallagher. Murine Models, Energy Balance, and Cancer. Energy Balance and Cancer 2015; 10: 153 doi: 10.1007/978-3-319-16733-6_8
|
| 4 |
G. Escobedo, M.C. Romano, J. Morales-Montor. Differentialin vitroeffects of insulin onTaenia crassicepsandTaenia soliumcysticerci. Journal of Helminthology 2009; 83(4): 403 doi: 10.1017/S0022149X09990265
|
| 5 |
Arezoo Gowhari Shabgah, Fatemeh Ezzatifar, Surendar Aravindhan, Angelina Olegovna Zekiy, Majid Ahmadi, Seyed Mohammad Gheibihayat, Jamshid Gholizadeh Navashenaq. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life 2021; 73(4): 659 doi: 10.1002/iub.2458
|
| 6 |
Min Yao, Li Wang, Junling Yang, Xiaodi Yan, Yin Cai, Dengfu Yao. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo. Tumor Biology 2016; 37(11): 14677 doi: 10.1007/s13277-016-5296-3
|
| 7 |
Diego Francesco Calvisi, Matthias Evert, Frank Dombrowski. Hepatocarcinogenesis following pancreatic islet transplantation in streptozotocin- and autoimmune-diabetic rats. Archives of Physiology and Biochemistry 2009; 115(2): 97 doi: 10.1080/13813450902870457
|
| 8 |
Tong Liu, Zheng Wang, Leiguang Ye, Yuran Duan, Hongfei Jiang, Haiyan He, Liwei Xiao, Qingang Wu, Yan Xia, Mengke Yang, Ke Wu, Meisi Yan, Guimei Ji, Yuli Shen, Lei Wang, Lin Li, Peixiang Zheng, Bofei Dong, Fei Shao, Xu Qian, Rilei Yu, Zhiren Zhang, Zhimin Lu, Daqian Xu. Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth. Nature Cell Biology 2023; doi: 10.1038/s41556-022-01061-0
|
| 9 |
Katsuhiro Ogawa. Molecular pathology of early stage chemically induced hepatocarcinogenesis. Pathology International 2009; 59(9): 605 doi: 10.1111/j.1440-1827.2009.02416.x
|
| 10 |
Xiancheng Chen, Xiaojuan Lin, Meng Li. Comprehensive Modulation of Tumor Progression and Regression with Periodic Fasting and Refeeding Circles via Boosting IGFBP-3 Loops and NK Responses. Endocrinology 2012; 153(10): 4622 doi: 10.1210/en.2011-2101
|
| 11 |
Jing Qian, Dengfu Yao, Zhizhen Dong, Wei Wu, Liwei Qiu, Ninghua Yao, Shanshan Li, Yinzhu Bian, Zhiwei Wang, Gongsheng Shi. Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular Carcinoma. American Journal of Clinical Pathology 2010; 134(5): 799 doi: 10.1309/AJCPTFDSE2V3LCZP
|
| 12 |
Eliot Osher, Valentine M. Macaulay. Therapeutic Targeting of the IGF Axis. Cells 2019; 8(8): 895 doi: 10.3390/cells8080895
|
| 13 |
Zhizhen Dong, Min Yao, Li Wang, Xiaodi Yan, Xing Gu, Yun Shi, Ninghua Yao, Liwei Qiu, Wei Wu, Dengfu Yao. Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells. Tumor Biology 2013; 34(6): 3397 doi: 10.1007/s13277-013-0912-y
|
| 14 |
Junlai Liu, Xiao Hu, Jie Chen, Xinqi Li, Lu Wang, Binbin Wang, Wenbo Peng, Cuiwei Yang, Zhijie Li, Yan Chen, Yue J. Wang, Chuanjiang Li, Xiajun Li, Fang Yan, Yunfang Wang, Changzhen Shang, Xin Wang, Tao Chen, Pengyu Huang. Pericentral hepatocytes produce insulin‐like growth factor‐2 to promote liver regeneration during selected injuries in mice. Hepatology 2017; 66(6): 2002 doi: 10.1002/hep.29340
|
| 15 |
K. Breuhahn. Molekulare Progressionsmechanismen der humanen Hepatokarzinogenese. Der Pathologe 2010; 31(S2): 170 doi: 10.1007/s00292-010-1337-7
|
| 16 |
Shaohui Tang, Yanfang Chen, Shufen Feng, Tingzhuang Yi, Xuyou Liu, Qiang Li, Zhilong Liu, Cuiping Zhu, Jianjun Hu, Xi Yu, Min Wang, Guoli Cao, Hui Tang, Caiqun Bie, Feng Ma, Huijun Tang, Gang Du, Jianwei Huang. MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma. Oncotarget 2017; 8(59): 99871 doi: 10.18632/oncotarget.21737
|
| 17 |
Mohammed A. F. Elewa, Mohammed M. Al-Gayyar, Mona F. Schaalan, Khaled H. Abd El Galil, Mohamed A. Ebrahim, Mamdouh M. El-Shishtawy. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Clinical & Experimental Metastasis 2015; 32(5): 479 doi: 10.1007/s10585-015-9721-6
|
| 18 |
Zijia Wang, Haofeng Xiong, Yijie Zuo, Shujun Hu, Chao Zhu, Anjie Min. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway. Cell Cycle 2022; 21(5): 477 doi: 10.1080/15384101.2021.2021722
|
| 19 |
Yan Ma, Yanfang Chen, Lei Chen, Zhi Liu, Mio-Leng Ieong, Fei Gao, Wei Huang. Promotion of Insulin-like growth factor II in cell proliferation and epithelial–mesenchymal transition in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2018; 14(4): 844 doi: 10.4103/jcrt.JCRT_605_17
|
| 20 |
Ulrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, Kira Simonsen, Poul Frølund Vestergaard, Jens Otto Lunde Jørgensen, Allan Flyvbjerg, Hendrik Vilstrup, Jan Frystyk. The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment. Growth Hormone & IGF Research 2015; 25(4): 174 doi: 10.1016/j.ghir.2015.05.002
|
| 21 |
Yilin Wang, Xiaolong Zhang, Chao Zou, Hsiang-Fu Kung, Marie C. Lin, Andreas Dress, Fiona Wardle, Bing-Hua Jiang, Lihui Lai. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer. Biomedicine & Pharmacotherapy 2016; 80: 95 doi: 10.1016/j.biopha.2016.03.007
|
| 22 |
Tamara Severi, Hannah van Malenstein, Chris Verslype, Jos F van Pelt. Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacologica Sinica 2010; 31(11): 1409 doi: 10.1038/aps.2010.142
|
| 23 |
Bo-Jun Tai, Min Yao, Wen-Jie Zheng, Yu-Cheng Shen, Li Wang, Jian-Ying Sun, Meng-Na Wu, Zhi-Zhen Dong, Deng-Fu Yao. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation. Hepatobiliary & Pancreatic Diseases International 2019; 18(2): 158 doi: 10.1016/j.hbpd.2019.01.003
|
| 24 |
Kimberly Terry, Mehmet Sitki Copur. Molecular Targeted Therapy of Hepatocellular Carcinoma. Journal of Cancer Therapy 2013; 4(02): 426 doi: 10.4236/jct.2013.42A052
|
| 25 |
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back. Tumori Journal 2013; 99(1): 10 doi: 10.1177/030089161309900102
|
| 26 |
Karen Bonefeld, Søren Møller. Insulin-like growth factor-I and the liver. Liver International 2011; 31(7): 911 doi: 10.1111/j.1478-3231.2010.02428.x
|
| 27 |
LU YUE, YING WANG, HUAMAO WANG, HUIPING GAO, JUN LIANG, AIHUA SUI, JINYU XIANG, FANG ZHOU, CONGCONG XU, WENWEN ZHAO, WANHUA LIANG, RUYONG YAO. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody. Oncology Reports 2012; 28(4): 1453 doi: 10.3892/or.2012.1960
|
| 28 |
YU GU, YUQIAO XU, LINA JIANG, XIANGMEI CAO, FANG LIU, HANG LI, LIYING ZHANG, ZENGSHAN LI, JING LI, JING YE, QING LI. Differentially expressed microRNAs in Huh-7 cells expressing HCV core genotypes 3a or 1b: Potential functions and downstream pathways. International Journal of Molecular Medicine 2012; 30(2): 374 doi: 10.3892/ijmm.2012.991
|
| 29 |
Astrid Slany, Anastasia Meshcheryakova, Agnes Beer, Hendrik Jan Ankersmit, Verena Paulitschke, Christopher Gerner. Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling. Clinical Proteomics 2014; 11(1) doi: 10.1186/1559-0275-11-41
|
| 30 |
Sameer A. Greenall, John D. Bentley, Lesley A. Pearce, Judith A. Scoble, Lindsay G. Sparrow, Nicola A. Bartone, Xiaowen Xiao, Robert C. Baxter, Leah J. Cosgrove, Timothy E. Adams. Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with Cancer. Journal of Biological Chemistry 2013; 288(1): 59 doi: 10.1074/jbc.M112.432013
|
| 31 |
Craig I. Campbell, James J. Petrik, Roger A. Moorehead. Insulin-like Growth Factors and Cancer. 2012; : 179 doi: 10.1007/978-1-4614-0598-6_9
|
| 32 |
O. V. Smirnova, F. A. Gershkoron. Role of insulin-like growth factor, pro-inflammatory and anti-inflammatory cytokines, transcription factors and adipokines in development of hepatocellular carcinoma in metabolic syndrome. Medical Immunology (Russia) 2022; 24(6): 1109 doi: 10.15789/1563-0625-ROI-2533
|
| 33 |
Tran Duc DUNG, Chih-Chung FENG, Wei-Wen KUO, Peiying PAI, Li-Chin CHUNG, Sheng-Huang CHANG, Hsi-Hsien HSU, Fuu-Jen TSAI, Yueh-Min LIN, Chih-Yang HUANG. Suppression of Plasminogen Activators and the MMP-2/-9 Pathway by aZanthoxylum avicennaeExtract to Inhibit the HA22T Human Hepatocellular Carcinoma Cell Migration and Invasion Effectsin Vitroandin VivoviaPhosphatase 2A Activation. Bioscience, Biotechnology, and Biochemistry 2013; 77(9): 1814 doi: 10.1271/bbb.130060
|
| 34 |
Yutaka Midorikawa, Yasuyuki Sugiyama, Hiroyuki Aburatani. Molecular targets for liver cancer therapy: From screening of target genes to clinical trials. Hepatology Research 2010; 40(1): 49 doi: 10.1111/j.1872-034X.2009.00583.x
|
| 35 |
Yulyana Yulyana, Ivy A W Ho, Kian Chuan Sia, Jennifer P Newman, Xin Yi Toh, Berwini B Endaya, Jerry K Y Chan, Massimiliano Gnecchi, Hung Huynh, Alexander Y F Chung, Kiat Hon Lim, Hui Sun Leong, Narayanan Gopalakrishna Iyer, Kam Man Hui, Paula Y P Lam. Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling. Molecular Therapy 2015; 23(4): 746 doi: 10.1038/mt.2015.13
|
| 36 |
Jin Gao, Jon W. Chesebrough, Susan A. Cartlidge, Sally-Ann Ricketts, Leonard Incognito, Margaret Veldman-Jones, David C. Blakey, Mohammad Tabrizi, Bahija Jallal, Pamela A. Trail, Steven Coats, Klaus Bosslet, Yong S. Chang. Dual IGF-I/II–Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth. Cancer Research 2011; 71(3): 1029 doi: 10.1158/0008-5472.CAN-10-2274
|
| 37 |
Daniel T. Dransfield, Edward H. Cohen, Qing Chang, Lindsay G. Sparrow, John D. Bentley, Olan Dolezal, Xiaowen Xiao, Thomas S. Peat, Janet Newman, Patricia A. Pilling, Tram Phan, Ilka Priebe, Gemma V. Brierley, Niksa Kastrapeli, Kris Kopacz, Diana Martik, Dina Wassaf, Douglas Rank, Greg Conley, Yan Huang, Timothy E. Adams, Leah Cosgrove. A Human Monoclonal Antibody against Insulin-Like Growth Factor-II Blocks the Growth of Human Hepatocellular Carcinoma Cell Lines In vitro and In vivo
. Molecular Cancer Therapeutics 2010; 9(6): 1809 doi: 10.1158/1535-7163.MCT-09-1134
|
| 38 |
Philippe Couvert, Alain Carrié, Sophie Tezenas du Montcel, Jenny Vaysse, Angela Sutton, Nathalie Barget, Jean-Claude Trinchet, Michel Beaugrand, Nathalie Ganne, Philippe Giral, Jamel Chelly. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis C related cirrhosis or hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2012; 36(4): 345 doi: 10.1016/j.clinre.2012.06.013
|
| 39 |
Jiangwei Li, Ren Li, Wei Jiang, Jin Sun, Jun Li, Ying Guo, Kai Zhu, Chen Zhang, Guangyao Kong, Zongfang Li. Splenic serum from portal hypertensive patients enhances liver stem cell proliferation and self-renewal via the IGF-II/ERK signaling pathway. Digestive and Liver Disease 2020; 52(2): 205 doi: 10.1016/j.dld.2019.07.014
|
| 40 |
Ying-Chun Shen, Chiun Hsu, Ann-Lii Cheng. Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives. Journal of Gastroenterology 2010; 45(8): 794 doi: 10.1007/s00535-010-0270-0
|
| 41 |
Anuradha Budhu, Junfang Ji, Xin Wei Wang. Hepatocellular Carcinoma. 2009; : 131 doi: 10.1007/978-1-60327-376-3_5
|
| 42 |
Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux, Christèle Desbois‐Mouthon. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. Liver International 2015; 35(10): 2203 doi: 10.1111/liv.12903
|
| 43 |
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
|
| 44 |
Dawn Qingqing Chong, Iain Beehuat Tan, Su-Pin Choo, Han Chong Toh. The evolving landscape of therapeutic drug development for hepatocellular carcinoma. Contemporary Clinical Trials 2013; 36(2): 605 doi: 10.1016/j.cct.2013.03.013
|
| 45 |
Astrid Slany, Verena J. Haudek, Hannes Zwickl, Nina C. Gundacker, Michael Grusch, Thomas S. Weiss, Katja Seir, Chantal Rodgarkia-Dara, Claus Hellerbrand, Christopher Gerner. Cell Characterization by Proteome Profiling Applied to Primary Hepatocytes and Hepatocyte Cell Lines Hep-G2 and Hep-3B. Journal of Proteome Research 2010; 9(1): 6 doi: 10.1021/pr900057t
|
| 46 |
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
|
| 47 |
Hamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, Dominique Wendum, Audrey Clapéron, Yves Chrétien, Colette Rey, Olivier Scatton, Olivier Soubrane, Filomena Conti, Françoise Praz, Chantal Housset, Olivier Rosmorduc, Christèle Desbois-Mouthon. Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors. Cancer Research 2013; 73(13): 3974 doi: 10.1158/0008-5472.CAN-12-3824
|
| 48 |
Shaohui Tang, Wei Hu, Jianjun Hu, Shenglan Wu, Junfeng Li, Yuhong Luo, Mingrong Cao, Hongke Zhou, Xiangwu Jiang. Hepatitis B virus X protein promotes P3 transcript expression of the insulin‐like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma. Liver International 2015; 35(2): 608 doi: 10.1111/liv.12469
|
| 49 |
Cai Qun Bie, Xu You Liu, Ming Rong Cao, Qiu Yan Huang, Hui Jun Tang, Min Wang, Guo Li Cao, Ting Zhuang Yi, Sheng Lan Wu, Wei Jie Xu, Shao Hui Tang. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression. Oncotarget 2016; 7(48): 79305 doi: 10.18632/oncotarget.13027
|
| 50 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 51 |
Julia C. Engelmann, Thomas Amann, Birgitta Ott-Rötzer, Margit Nützel, Yvonne Reinders, Jörg Reinders, Wolfgang E. Thasler, Theresa Kristl, Andreas Teufel, Christian G. Huber, Peter J. Oefner, Rainer Spang, Claus Hellerbrand, Sven Nelander. Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma. PLOS Computational Biology 2015; 11(5): e1004293 doi: 10.1371/journal.pcbi.1004293
|
| 52 |
Natalia Elfimova, Elisabeth Sievers, Hannah Eischeid, Monika Kwiecinski, Andrea Noetel, Heike Hunt, Diana Becker, Peter Frommolt, Maria Quasdorff, Hans Michael Steffen, Peter Nürnberg, Reinhard Büttner, Andreas Teufel, Hans-Peter Dienes, Uta Drebber, Margarete Odenthal. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013; 1833(5): 1190 doi: 10.1016/j.bbamcr.2013.01.023
|
| 53 |
Ahmed Waraky, Eiman Aleem, Olle Larsson. Downregulation of IGF-1 receptor occurs after hepatic linage commitment during hepatocyte differentiation from human embryonic stem cells. Biochemical and Biophysical Research Communications 2016; 478(4): 1575 doi: 10.1016/j.bbrc.2016.08.157
|
| 54 |
Ke Wu, Meisi Yan, Tong Liu, Zheng Wang, Yuran Duan, Yan Xia, Guimei Ji, Yuli Shen, Lei Wang, Lin Li, Peixiang Zheng, Bofei Dong, Qingang Wu, Liwei Xiao, Xueying Yang, Haochen Shen, Ting Wen, Jingjing Zhang, Jinfeng Yi, Yuhan Deng, Xu Qian, Leina Ma, Jing Fang, Qin Zhou, Zhimin Lu, Daqian Xu. Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function. Nature Cell Biology 2023; 25(5): 714 doi: 10.1038/s41556-023-01133-9
|
| 55 |
Sameer A. Greenall, Jacqueline Donoghue, Terrance G. Johns, Timothy E. Adams. Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3. Translational Oncology 2018; 11(4): 971 doi: 10.1016/j.tranon.2018.05.011
|
| 56 |
Priscilla T.-Y. Law, Arthur K.-K. Ching, Anthony W.-H. Chan, Queenie W.-L. Wong, Chun-Kwok Wong, Ka-Fai To, Nathalie Wong. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Carcinogenesis 2012; 33(6): 1134 doi: 10.1093/carcin/bgs130
|